|
发表于 2-10-2009 03:37 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 2-10-2009 03:42 PM
|
显示全部楼层
原帖由 葉芬 于 2-10-2009 02:11 PM 发表 
2.50 應該是沒問題。
承你贵言。
谢谢Mike哥的分享。 |
|
|
|
|
|
|
|
发表于 2-10-2009 03:50 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 2-10-2009 04:24 PM
|
显示全部楼层
你好! 我也买了@1。76 。(价钱好象高一点。)
希望今晚有好戏看。 |
|
|
|
|
|
|
|
发表于 2-10-2009 04:32 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 2-10-2009 04:38 PM
|
显示全部楼层
回复 43# 葉芬 的帖子
我也笑了。。。。。。
 |
|
|
|
|
|
|
|
发表于 2-10-2009 04:40 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 2-10-2009 04:45 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 2-10-2009 04:48 PM
|
显示全部楼层
原帖由 pink0905 于 2-10-2009 04:40 PM 发表 
我只有2000unit。
买美国股票真的很伤身体心情七上八下的。
(可以帮我看看crbc如何?)
對不起,CRBC我不熟悉,沒有研究。
不過只能說一句 買進小的金融股要小心,
買時自己要知道小金融股的風險很高。 |
|
|
|
|
|
|
|
发表于 2-10-2009 04:49 PM
|
显示全部楼层
回复 48# 葉芬 的帖子
我没买。。
pm你了,关于让我笑的事。。。

[ 本帖最后由 wobushi 于 2-10-2009 04:55 PM 编辑 ] |
|
|
|
|
|
|
|
发表于 2-10-2009 04:52 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 2-10-2009 07:49 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 2-10-2009 07:55 PM
|
显示全部楼层
原帖由 ocs88 于 2-10-2009 07:49 PM 发表 
你好! 我也买了cvm 0.45
嘩 。。正點! 1流價錢。。
 |
|
|
|
|
|
|
|
发表于 2-10-2009 07:57 PM
|
显示全部楼层
Cel-Sci Corporation (CVM) Pre-Market Trading
Pre-Market Last: $ 1.87
Pre-Market High: $ 1.87
Pre-Market Volume: 500
Pre-Market Low: $ 1.87 |
|
|
|
|
|
|
|
发表于 2-10-2009 08:54 PM
|
显示全部楼层
今晚的Future不是很妙。。。。。
Mini Dow Jones Indus.-$5 Dec 09 9,364.00 8:39am ET Down 107.00 (1.13%)
CVM 給這瓜這樣寫下。。股價往下走了。。
(以前的CTIC 及 HEB 大漲時,他也是出來說壞話 )
Biotech Mailbag: Cel-Sci, BioElectronics
By Adam Feuerstein 10/02/09 - 06:56 AM EDT
http://www.thestreet.com/story/1 ... html?cm_ven=GOOGLEN |
|
|
|
|
|
|
|
发表于 2-10-2009 09:19 PM
|
显示全部楼层
|
|
|
|
|
|
|
发表于 2-10-2009 09:29 PM
|
显示全部楼层
回复 56# 雨后的秋林 的帖子
我同意你的说法。现在我一直在准备等它红红就进场。
昨天献出我的第一次
随便进了少少的lvs。其他一律不敢动 |
|
|
|
|
|
|
|
发表于 2-10-2009 10:07 PM
|
显示全部楼层
原帖由 葉芬 于 2-10-2009 08:54 PM 发表 
今晚的Future不是很妙。。。。。
Mini Dow Jones Indus.-$5 Dec 09 9,364.00 8:39am ET Down 107.00 (1.13%)
CVM 給這瓜這樣寫下。。股價往下走了。。
(以前的CTIC 及 HEB 大漲時,他也是出來說壞話 :s ...
终于给ADAM看中了,这条水不懂讲他见解独到好,还是死口一张好。。。不过他唱衰的股通常真的都几衰一下 |
|
|
|
|
|
|
|
发表于 3-10-2009 09:54 AM
|
显示全部楼层
原帖由 葉芬 于 2-10-2009 08:54 PM 发表 
今晚的Future不是很妙。。。。。
Mini Dow Jones Indus.-$5 Dec 09 9,364.00 8:39am ET Down 107.00 (1.13%)
CVM 給這瓜這樣寫下。。股價往下走了。。
(以前的CTIC 及 HEB 大漲時,他也是出來說壞話 :s ...
終于有人出來說句公道話。。。
(將來有見到 TheStreet.Com's 》》 這瓜 “Adam Feuerstein” 寫的東西,別相信也別讀它。。)
Written by M.E.Garza | Friday, 02 October 2009 04:15 |
Thefollowing is my own opinion and not the opinion of any of the newsorganizations, syndicates, publishers or others who distribute this"penny pumping" content. At least, not on the record.
|
Does anyone still buy that garbage known as "The BioTech Mailbag"that TheStreet.Com's Adam Feuerstein writes? If so, why? When was thelast time anyone made any good investment decisions based on thefallacious bunk that guy publishes? Seriously!
The failed fundmanager, turned writer uses it as a platform to launch personal attacksat anyone who disagrees with him or thinks that he has a personal (orfinancial) agenda against him.
Isn't it long time that you come clean Mr. Feuerstein?
Comeout from behind the veil of constitutionally protected free speech andstart taking responsibility for some of the mistakes and millionsyou've caused companies and investors to lose.....
http://biomedreports.com/articles/most-popular/11704-opinion-qadam-whoq.html |
|
|
|
|
|
|
|
发表于 3-10-2009 10:12 AM
|
显示全部楼层
我帖出以下的信息,讓大家比較清楚CVM即將來的走勢。。
(這只是其中的一種,接下來還有多樣的藥物等著出。可參考我第一頁的帖子。)
http://www.americanchronicle.com/articles/view/120959#
FDA staff were presented with a number of novel drugs and medical
devices that might make a difference the battle against H1N1 and which
might be considered for Emergency Use Authorization.
So far only one proposed treatment has met the stringent safety and
efficacy requirements to be fast tracked into human studies. That
treatment was being developed by Virginia based, Cel-Sci Corporation
and is based on their Ligand Epitope Antigen Presentation System.
Animal study results and technology data were compelling enough to
make the FDA grant the company overnight approval to move directly
into human trials of the treatment. The novel T-cell modulation
platform enables Cel-Sci to design and synthesize proprietary
immunogens and provides the ability to preferentially direct the
immune system. The technology was considered a major breakthrough it
was presented to a prestigious group of scientists from academia, bio-
tech, large pharmaceutical companies and the FDA in 1995, but it has
taken years of patient research to develop the approach to this point.
Last week, the company hired a full-service Clinical Research
Organization (CRO) with an office in the Washington, D.C./Baltimore
area to support its research and report findings as quickly as
possible to the FDA.
Other treatments which were presented, but did not yet make it to the
next round included:
DAS181 or Fludase developed by NanoViricides, Inc. is headed back to
for more testing, this time with Southern Research, a company
registered with the CDC that stores several dangerous pathogens,
including the current novel Influenza A/California/4/2009 H1N1 isolate
("swine flu") from the Centers for Disease Control (CDC).
[ 本帖最后由 葉芬 于 3-10-2009 10:15 AM 编辑 ] |
|
|
|
|
|
|
| |
本周最热论坛帖子
|